[1]
I.-H. Wu, “Comparison of Cardiovascular Risks following Smoking Cessation Treatments Using Varenicline vs. NRT among Schizophrenic Smokers”, Arch Psychiatr Ment Health, vol. 1, no. 1, pp. 001–010, Oct. 2017.